应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
03696 英矽智能
已收盘 09-28 16:08:28
53.800
-1.850
-3.32%
最高
57.250
最低
52.900
成交量
1,473万
今开
56.150
昨收
55.650
日振幅
7.82%
总市值
313.65亿
流通市值
313.65亿
总股本
5.83亿
成交额
8.04亿
换手率
2.53%
流通股本
5.83亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
英矽智能:Norges Bank减持,好仓比例降至3.15%
港股披露 · 09-24
英矽智能:Norges Bank减持,好仓比例降至3.15%
富瑞:英硅智能(03696.HK)药物资产重要性胜于专有模型 维持“买入”评级
智通财经 · 09-24
富瑞:英硅智能(03696.HK)药物资产重要性胜于专有模型 维持“买入”评级
异动解读|英矽智能盘中下跌5.03%,增发新股摊薄叠加生命科学板块集体走弱
行情直击 · 09-24
异动解读|英矽智能盘中下跌5.03%,增发新股摊薄叠加生命科学板块集体走弱
英矽智能:Aleksandrs Zavoronkovs被动摊薄,好仓比例降至7.99%
港股披露 · 09-23
英矽智能:Aleksandrs Zavoronkovs被动摊薄,好仓比例降至7.99%
英矽智能:Norges Bank同日披露权益变动
港股披露 · 09-23
英矽智能:Norges Bank同日披露权益变动
异动解读|英矽智能盘中下跌5.02%,报60.5港元
行情直击 · 09-23
异动解读|英矽智能盘中下跌5.02%,报60.5港元
英硅智能(03696.HK)获摩根大通增持183.05万股
中金财经 · 09-22
英硅智能(03696.HK)获摩根大通增持183.05万股
英矽智能:摩根大通增持,好仓比例升至6.06%
港股披露 · 09-22
英矽智能:摩根大通增持,好仓比例升至6.06%
港股公告掘金 | 英硅智能:达成一项合约价值最高达数千万美元的AI联合开发合作,构建并商业化生物学基础模型
智通财经 · 09-22
港股公告掘金 | 英硅智能:达成一项合约价值最高达数千万美元的AI联合开发合作,构建并商业化生物学基础模型
小摩:维持英硅智能(03696.HK)“增持”评级 目标价71港元
智通财经 · 09-21
小摩:维持英硅智能(03696.HK)“增持”评级 目标价71港元
港股异动 | 英硅智能(03696.HK)午后涨近6% 达成数千万美元AI模型共建合作 构建并商业化生物学基础模型
智通财经 · 09-21
港股异动 | 英硅智能(03696.HK)午后涨近6% 达成数千万美元AI模型共建合作 构建并商业化生物学基础模型
英硅智能(03696):达成一项合约价值最高达数千万美元的AI联合开发合作,构建并商业化生物学基础模型
智通财经 · 09-21
英硅智能(03696):达成一项合约价值最高达数千万美元的AI联合开发合作,构建并商业化生物学基础模型
英矽智能(03696)宣布与前沿基礎模型實驗室達成最高數千萬美元AI聯合開發合作
公告速递 · 09-21
英矽智能(03696)宣布与前沿基礎模型實驗室達成最高數千萬美元AI聯合開發合作
英矽智能达成合作,利用Mmai Gym框架开发生物研究基础模型
美股速递 · 09-21
英矽智能达成合作,利用Mmai Gym框架开发生物研究基础模型
英矽智能签署AI联合开发合作,合同价值或达数千万美元
美股速递 · 09-21
英矽智能签署AI联合开发合作,合同价值或达数千万美元
异动解读|英矽智能盘中上涨5.35%,III期临床里程碑与董事长增持持续催化
行情直击 · 09-21
异动解读|英矽智能盘中上涨5.35%,III期临床里程碑与董事长增持持续催化
Tempus大涨之后,德适科技(02526)的AI4S价值正在被重新发现
智通财经 · 09-19
Tempus大涨之后,德适科技(02526)的AI4S价值正在被重新发现
英矽智能:摩根大通减持,好仓比例降至5.96%
港股披露 · 09-18
英矽智能:摩根大通减持,好仓比例降至5.96%
大和:英硅智能(03696.HK)BD及PCC产出创纪录高 上半年收入同比升287.2%至1.06亿美元
智通财经 · 09-18
大和:英硅智能(03696.HK)BD及PCC产出创纪录高 上半年收入同比升287.2%至1.06亿美元
港股午评|恒生指数早盘涨0.67% AI制药板块大涨
智通财经 · 09-18
港股午评|恒生指数早盘涨0.67% AI制药板块大涨
加载更多
公司概况
公司名称:
英矽智能
所属市场:
SEHK
上市日期:
--
主营业务:
英矽智能是一家主要从事人工智能驱动的药物发现及管线开发业务的公司。该公司主要业务包括自主开发候选药物,共同开发,授权药物并保留部分知识产权及与其他制药公司合作但不保留任何知识产权。该公司通过自主开发的人工智能平台 Pharma.AI产生了多项临床或新药临床试验申请阶段的资产。此外,该公司也涉足软体解决方案和其他与非制药领域相关的研发业务。
发行价格:
--
{"stockData":{"symbol":"03696","market":"HK","secType":"STK","nameCN":"英矽智能","latestPrice":53.8,"timestamp":1790582908006,"preClose":55.65,"halted":0,"volume":14734039,"delay":0,"changeRate":-0.03324348607367478,"floatShares":583000000,"shares":583000000,"eps":-4.48,"marketStatus":"已收盘","change":-1.85,"latestTime":"09-28 16:08:28","open":56.15,"high":57.25,"low":52.9,"amount":803545247,"amplitude":0.078167,"askPrice":53.8,"askSize":67000,"bidPrice":53.75,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":-4.006,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790645400000},"marketStatusCode":5,"adr":0,"listingDate":1767024000000,"exchange":"SEHK","adjPreClose":55.65,"openAndCloseTimeList":[[1790559000000,1790568000000],[1790571600000,1790582400000]],"volumeRatio":0.914496,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03696","defaultTab":"news","newsList":[{"id":"1117953142","title":"英矽智能:Norges Bank减持,好仓比例降至3.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=1117953142","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117953142?lang=zh_cn&edition=full","pubTime":"2026-09-24 17:16","pubTimestamp":1790241364,"startTime":"0","endTime":"0","summary":"于2026年9月22日,Norges Bank因收回抵押股份(Collateral shares returned),通过场外非现金资产交易减持英矽智能股份。该笔交易属场外交易(代价性质:非现金资产),未经联交所公开市场撮合,不属二级市场直接买卖。Norges Bank此次减持前持有英矽智能好仓3025.12万股,占比5.19%;减持后持股量为1832.71万股,好仓比例降至3.15%。淡仓方面,减持前持有2083.73万股(3.58%),减持后持有891.31万股(1.53%)。原文链接:Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669452145","title":"富瑞:英硅智能(03696.HK)药物资产重要性胜于专有模型 维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2669452145","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669452145?lang=zh_cn&edition=full","pubTime":"2026-09-24 14:48","pubTimestamp":1790232501,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166047228","title":"异动解读|英矽智能盘中下跌5.03%,增发新股摊薄叠加生命科学板块集体走弱","url":"https://stock-news.laohu8.com/highlight/detail?id=1166047228","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166047228?lang=zh_cn&edition=full","pubTime":"2026-09-24 13:57","pubTimestamp":1790229458,"startTime":"0","endTime":"0","summary":"9月24日,英矽智能盘中下跌5.03%,报55.7港元/股,成交额6.49亿港元,延续前一交易日跌势。消息面上,公司近期因增发新股,导致董事长Aleksandrs Zavoronkovs持股比例由8.02%被动摊薄至7.99%,市场对股本扩张存在一定担忧。与此同时,生命科学工具和服务板块整体承压,金斯瑞生物科技跌6.18%,晶泰控股跌3.10%,药明生物跌2.18%,药明合联跌1.37%,药明康德跌1.16%,行业个股全线下挫,进一步拖累公司股价表现。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"英矽智能增发摊薄,随板块走弱下探","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138788541","title":"英矽智能:Aleksandrs Zavoronkovs被动摊薄,好仓比例降至7.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=1138788541","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138788541?lang=zh_cn&edition=full","pubTime":"2026-09-23 17:50","pubTimestamp":1790157049,"startTime":"0","endTime":"0","summary":"Aleksandrs Zavoronkovs因英矽智能增发新股,该变动并非在联交所公开市场直接买卖股份,而是由于公司发行新股导致持股比例被动摊薄。Aleksandrs Zavoronkovs此次被动摊薄前持有英矽智能好仓4675.70万股,占比8.02%;被动摊薄后持股量仍为4675.70万股,好仓比例降至7.99%。原文链接:Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142788794","title":"英矽智能:Norges Bank同日披露权益变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1142788794","media":"港股披露","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142788794?lang=zh_cn&edition=full","pubTime":"2026-09-23 17:24","pubTimestamp":1790155452,"startTime":"0","endTime":"0","summary":"Norges Bank于2026年9月21日通过收取有归还义务的抵押股份的方式增持英矽智能好仓,该笔交易属场外交易,代价性质为非现金资产,并非在联交所公开市场直接买卖。同日,其淡仓持股数目不变,因英矽智能回购注销股份,淡仓比例被动上升。Norges Bank此次增持前持有英矽智能好仓2688.95万股,占比4.61%;增持后持股量为3025.12万股,好仓比例升至5.19%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120388974","title":"异动解读|英矽智能盘中下跌5.02%,报60.5港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1120388974","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120388974?lang=zh_cn&edition=full","pubTime":"2026-09-23 13:23","pubTimestamp":1790141029,"startTime":"0","endTime":"0","summary":"9月23日,英矽智能盘中下跌5.02%,报60.5港元/股,成交额4.4亿港元。英矽智能所在的生命科学工具和服务行业中,个股表现分化,金斯瑞生物科技涨4.35%,药明生物跌0.19%,晶泰控股跌1.15%,药明康德跌0.38%,药明合联跌0.19%。英矽智能是一家主要从事人工智能驱动的药物发现及管线开发业务的公司,通过自主开发的人工智能平台Pharma.AI产生了多项临床或新药临床试验申请阶段的资产,此外也涉足软体解决方案和其他与非制药领域相关的研发业务。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669239971","title":"英硅智能(03696.HK)获摩根大通增持183.05万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669239971","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669239971?lang=zh_cn&edition=full","pubTime":"2026-09-22 22:57","pubTimestamp":1790089021,"startTime":"0","endTime":"0","summary":"格隆汇8月12日丨根据联交所最新权益披露资料显示,2026年8月7日,英硅智能(03696.HK)获JPMorgan Chase & Co.以每股均价43.6099港元增持好仓183.05万股,涉资约7982.8万港元。\n\n 增持后,JPMorgan Chase & Co.最新持好仓数目为2970.81万股,持好仓比例由4.81%上升至5.10%。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/22/20260922499798.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/22/20260922499798.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260922/32378300.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["03696","BK1141","PGF","BK4582"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174340928","title":"英矽智能:摩根大通增持,好仓比例升至6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=1174340928","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174340928?lang=zh_cn&edition=full","pubTime":"2026-09-22 17:24","pubTimestamp":1790069059,"startTime":"0","endTime":"0","summary":"摩根大通于2026年9月17日以每股均价53.1573港元场外买入英矽智能(03696)61.24万股股份,涉资约3255.48万港元。该笔为场外交易(代价性质:现金),未经联交所公开市场撮合,不属二级市场直接买卖。摩根大通此次增持前持有英矽智能好仓3472.95万股,占比5.96%;增持后持股量为3534.20万股,好仓比例升至6.06%。原文链接:Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669194666","title":"港股公告掘金 | 英硅智能:达成一项合约价值最高达数千万美元的AI联合开发合作,构建并商业化生物学基础模型","url":"https://stock-news.laohu8.com/highlight/detail?id=2669194666","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669194666?lang=zh_cn&edition=full","pubTime":"2026-09-22 09:00","pubTimestamp":1790038849,"startTime":"0","endTime":"0","summary":"重大事项:欢创科技(06802)拟全球发售1158.88万股 预计9月30日上市纳真科技(09856):香港公开发售获35.16倍认购 每股发售价32.96港元劲方医药-B(02595):股价近日有所上升,临床项目GFH375联合西妥昔单抗联合疗法拟纳入突破性疗法认定名单翰思艾泰-B(03378)与晶泰科技签署战略合作框架协议及XtalPi Science技术平台使用授权协议顺丰控股(06936)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1499101.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06936","BK1589","BK1155","KCAI","QTOC","BK1586","BK1161","CHAT","BK1518","VXUS","AIPO","BK1147","BK4588","BK1151","BK1141","LU2213484517.USD","02595","00354","01911","BK4585","VTHR","AGIX","BK1526","ARTY","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669155935","title":"小摩:维持英硅智能(03696.HK)“增持”评级 目标价71港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669155935","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669155935?lang=zh_cn&edition=full","pubTime":"2026-09-21 15:39","pubTimestamp":1789976358,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669106137","title":"港股异动 | 英硅智能(03696.HK)午后涨近6% 达成数千万美元AI模型共建合作 构建并商业化生物学基础模型","url":"https://stock-news.laohu8.com/highlight/detail?id=2669106137","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669106137?lang=zh_cn&edition=full","pubTime":"2026-09-21 13:37","pubTimestamp":1789969036,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669132623","title":"英硅智能(03696):达成一项合约价值最高达数千万美元的AI联合开发合作,构建并商业化生物学基础模型","url":"https://stock-news.laohu8.com/highlight/detail?id=2669132623","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669132623?lang=zh_cn&edition=full","pubTime":"2026-09-21 12:31","pubTimestamp":1789965100,"startTime":"0","endTime":"0","summary":"智通财经APP讯,英硅智能(03696)发布公告,公司已与一家前沿基础模型实验室达成一项合约金额最高达数千万美元的合作。根据协议,双方将依托MMAI Gym训练框架,共同开发、验证并商业化一系列专为生物学研究打造的前沿基础模型。根据合作条款,双方将深度整合各自优势,构建面向生成式生物学的专用基础模型。英硅智能将提供涵盖多项专门生命科学任务的专有数据集,并针对基础模型在训练过程中生成的结果,开展闭环式湿实验验证。此外,双方建立收益共享模式,依托各自在生物医药领域的合作伙伴网络,推动全球商业化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1498591.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["QTOC","ARTY","AIPO","03696","AGIX","BK1141","VTHR","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190670172","title":"英矽智能(03696)宣布与前沿基礎模型實驗室達成最高數千萬美元AI聯合開發合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1190670172","media":"公告速递","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190670172?lang=zh_cn&edition=full","pubTime":"2026-09-21 12:30","pubTimestamp":1789965033,"startTime":"0","endTime":"0","summary":"2026年9月21日,英矽智能(03696)发布自愿公告称,公司已与一家前沿基礎模型實驗室签署合约金额最高达數千萬美元的合作协议,双方将基于MMAI Gym训练框架共同开发、验证并商业化面向生物学研究的基礎模型。 \\n\\n根据协议,英矽智能将提供涵盖多项生命科学任务的专有数据集,并在模型训练过程中对生成结果进行闭环式湿实验验证。合作双方将整合各自在生物医药领域的合作伙伴网络,建立收益共享模式以推进全球商业化。 \\n\\n公告提醒投资者,所有前瞻性陈述并无保证实现,相关财务及其他数据未经核数师审阅。公司股东及潜在投资者在买卖公司股份时应保持审慎,并在需要时寻求专业意见。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138416603","title":"英矽智能达成合作,利用Mmai Gym框架开发生物研究基础模型","url":"https://stock-news.laohu8.com/highlight/detail?id=1138416603","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138416603?lang=zh_cn&edition=full","pubTime":"2026-09-21 12:27","pubTimestamp":1789964833,"startTime":"0","endTime":"0","summary":"英矽智能近日宣布一项重要合作协议。该协议旨在借助Mmai Gym框架,全力推进面向生物研究领域的基础模型开发。此举标志着英矽智能在人工智能驱动药物发现与生物探索的征途上,再度迈出关键一步。Mmai Gym框架作为一项创新性技术平台,将为英矽智能提供强大的支撑。基础模型的开发,被视为解锁生物数据潜在价值的关键钥匙,而Mmai Gym框架的应用,则为这一进程注入了新的活力。协议的达成,无疑为英矽智能的未来发展增添了浓墨重彩的一笔。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177704674","title":"英矽智能签署AI联合开发合作,合同价值或达数千万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1177704674","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177704674?lang=zh_cn&edition=full","pubTime":"2026-09-21 12:27","pubTimestamp":1789964828,"startTime":"0","endTime":"0","summary":"英矽智能(Insilico Medicine Cayman Topco)宣布达成一项AI联合开发合作,合同价值预计可达数千万美元。这一合作标志着该公司在人工智能药物研发领域的进一步深化布局,有望推动更多创新疗法快速进入临床阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121954097","title":"异动解读|英矽智能盘中上涨5.35%,III期临床里程碑与董事长增持持续催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1121954097","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121954097?lang=zh_cn&edition=full","pubTime":"2026-09-21 09:48","pubTimestamp":1789955322,"startTime":"0","endTime":"0","summary":"9月21日,英矽智能盘中上涨5.35%,报64.05港元,成交额3.82亿港元。消息面上,公司核心AI驱动候选药物Rentosertib于9月10日在北京协和医院完成III期临床试验GENESIS-IPF-3首例患者入组及给药,系全球首个生成式AI驱动创新药迈入III期的里程碑事件。该试验为期52周,将纳入320名受试者,评估Rentosertib对特发性肺纤维化的疗效。花旗维持公司\"买入\"评级,目标价85港元,将其列为AI药物发现子板块首选。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"英矽智能盘中上涨,AI新药III期突破引关注","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668957971","title":"Tempus大涨之后,德适科技(02526)的AI4S价值正在被重新发现","url":"https://stock-news.laohu8.com/highlight/detail?id=2668957971","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668957971?lang=zh_cn&edition=full","pubTime":"2026-09-19 09:12","pubTimestamp":1789780357,"startTime":"0","endTime":"0","summary":"同日德适收涨0.39%。Tempus的经营数据给出了线索。沿着这条线研究德适,可以看到一家更接近AI4S本质的公司。iMedLoop于7月上线,晚于上半年报告期。德适正在构建AI4S看重的“发现问题—组织数据—训练模型—验证效果—重新交付”闭环。Tempus的行情提醒市场,高质量医学数据进入真实工作流并产生商业回报,才更有基础获得更高定价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1498329.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","07666","02526","BK1161","BK1100","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106214049","title":"英矽智能:摩根大通减持,好仓比例降至5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=1106214049","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106214049?lang=zh_cn&edition=full","pubTime":"2026-09-18 17:22","pubTimestamp":1789723353,"startTime":"0","endTime":"0","summary":"摩根大通于2026年9月15日以每股均价51.0608港元场外卖出英矽智能449.82万股,涉资约2.30亿港元,属场外交易,未经联交所公开市场撮合,不属二级市场直接买卖。同时,摩根大通因场外股本衍生工具到期注销,淡仓减少,淡仓比例由3.09%降至2.89%,该笔属场外衍生品交易,并非在二级市场直接买卖正股。摩根大通此次减持前持有英矽智能好仓3927.76万股,占比6.74%;减持后持股量为3477.94万股,好仓比例降至5.96%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668394873","title":"大和:英硅智能(03696.HK)BD及PCC产出创纪录高 上半年收入同比升287.2%至1.06亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2668394873","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668394873?lang=zh_cn&edition=full","pubTime":"2026-09-18 14:52","pubTimestamp":1789714321,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1141","03696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668191239","title":"港股午评|恒生指数早盘涨0.67% AI制药板块大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2668191239","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668191239?lang=zh_cn&edition=full","pubTime":"2026-09-18 12:00","pubTimestamp":1789704004,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,港股恒生指数涨0.67%,涨164点,报24768点;恒生科技指数涨1.74%。港股早盘成交1070亿港元。十部门印发医药十五五规划,机构看好医药迎“Claude”时刻。AI制药进入战略入局阶段。曦智科技-P涨超17%。天数智芯涨超13%,公司有望持续受益AI资本开支的增长及算力自主可控浪潮。MINIMAX-W涨13%,旗下多款产品通过Singtel AI Pass纳入配套订阅计划。俊知集团涨超10%,收购青海中利光纤技术有望打开AI算力相关光纤产品增量空间。大股东解禁期满。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1497792.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MCHmain","BK1617","07552","LU1267930227.SGD","LU1831875114.USD","BK1149","02142","BK1506","IE0003895053.USD","LU1046422090.SGD","LU0128525689.USD","LU0320764755.SGD","LU0828237940.HKD","LU1188198961.HKD","LU0348827113.USD","01787","02656","HK0000306685.HKD","01818","LU0348825331.USD","83115","BK1141","06127","03696","03037","LU0890818403.SGD","07666","01879","IE00B0JY6N72.USD","02701","BK1592","LU0264606111.USD","BK1526","03088","BK1197","BK1576","07226","LU1785774172.SGD","HHImain","07500","LU2242644610.SGD","LU0244354667.USD","02837","IE0032431581.USD","BK1583","LU0561508036.HKD","LU1366334578.USD","BK1183","BK1117","02670","LU0543330483.HKD","07630","LU0181495838.USD","09115","LNVGY","HK0000320223.HKD","LU0326950275.SGD","300077","LU0049112450.USD","LU0048580855.USD","LU1808992512.USD","LU0463099449.HKD","LU0862451753.SGD","07300","LU0791590937.USD","82800","BK1163","HSI","LU0417516902.SGD","HSTECH","TCHI","09903","LU0572940350.SGD","IE0034224299.USD","03067","01300","LU0791591158.USD","LU0672654166.SGD","03419","02228","BK1544","HK0000306701.USD","09088","00992","02833","03032","03423","09067","600547","BK1237","BK1574","BK1161","LU0310800965.SGD","LU0972618739.USD","LU0029875118.USD","BK1198","06658","02800","LU0140636845.USD","LU0128522157.USD","03115","07200","LU0052756011.USD","LU1366334651.USD","LU0862451837.USD","80992","513600","LU0572939691.SGD","00100","03033","603127","BK1607","03417","LU1235295612.USD","BK1193","LU0370786039.SGD","HK0000320264.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://insilico.com","stockEarnings":[{"period":"1week","weight":-0.0847},{"period":"1month","weight":0.184},{"period":"3month","weight":0.456},{"period":"6month","weight":-0.0271},{"period":"1year","weight":1.3139},{"period":"ytd","weight":0.4984}],"compareEarnings":[{"period":"1week","weight":-0.0097},{"period":"1month","weight":-0.0446},{"period":"3month","weight":0.0811},{"period":"6month","weight":-0.0177},{"period":"1year","weight":-0.0746},{"period":"ytd","weight":-0.0437}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"英矽智能是一家主要从事人工智能驱动的药物发现及管线开发业务的公司。该公司主要业务包括自主开发候选药物,共同开发,授权药物并保留部分知识产权及与其他制药公司合作但不保留任何知识产权。该公司通过自主开发的人工智能平台 Pharma.AI产生了多项临床或新药临床试验申请阶段的资产。此外,该公司也涉足软体解决方案和其他与非制药领域相关的研发业务。","exchange":"SEHK","name":"英矽智能","nameEN":"INSILICO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"英矽智能(03696)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供英矽智能(03696)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"英矽智能,03696,英矽智能股票,英矽智能股票老虎,英矽智能股票老虎国际,英矽智能行情,英矽智能股票行情,英矽智能股价,英矽智能股市,英矽智能股票价格,英矽智能股票交易,英矽智能股票购买,英矽智能股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"英矽智能(03696)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供英矽智能(03696)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}